A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline

BACKGROUND: Eravacycline is a novel fluorocycline approved for treatment of intraabdominal infections, with a broad spectrum of activity against a range of pathogens including multidrug-resistant species, including ESBL- or KPC-producing isolates. It is approved for twice-daily dosing with no need f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Infect Dis Ther
Main Authors: Van Hise, Nicholas, Petrak, Russell M., Skorodin, Nathan C., Fliegelman, Robert M., Anderson, Michael, Didwania, Vishal, Han, Alice, Shah, Kairav, Chundi, Vishnu, Hines, David, Roig, Ingrid, Kalra, Apoorv
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7680490/
https://ncbi.nlm.nih.gov/pubmed/33063176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-020-00351-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados